Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Invest Ophthalmol Vis Sci ; 62(14): 20, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34797906

ABSTRACT

Purpose: The purpose of this study was to present our hypothesis that aging alters metabolic function in ocular tissues. We tested the hypothesis by measuring metabolism in aged murine tissues alongside retinal responses to light. Methods: Scotopic and photopic electroretinogram (ERG) responses in young (3-6 months) and aged (23-26 months) C57Bl/6J mice were recorded. Metabolic flux in retina and eyecup explants was quantified using U-13C-glucose or U-13C-glutamine with gas chromatography-mass spectrometry (GC-MS), O2 consumption rate (OCR) in a perifusion apparatus, and quantifying adenosine triphosphatase (ATP) with a bioluminescence assay. Results: Scotopic and photopic ERG responses were reduced in aged mice. Glucose metabolism, glutamine metabolism, OCR, and ATP pools in retinal explants were mostly unaffected in aged mice. In eyecups, glutamine usage in the Krebs Cycle decreased while glucose metabolism, OCR, and ATP pools remained stable. Conclusions: Our examination of metabolism showed negligible impact of age on retina and an impairment of glutamine anaplerosis in eyecups. The metabolic stability of these tissues ex vivo suggests age-related metabolic alterations may not be intrinsic. Future experiments should focus on determining whether external factors including nutrient supply, oxygen availability, or structural changes influence ocular metabolism in vivo.


Subject(s)
Aging/physiology , Retina/metabolism , Retinal Pigment Epithelium/metabolism , Adenosine Triphosphate/metabolism , Animals , Color Vision/physiology , Electroretinography , Flicker Fusion/physiology , Gas Chromatography-Mass Spectrometry , Glucose/metabolism , Glutamine/metabolism , Light , Male , Metabolomics , Mice , Mice, Inbred C57BL , Night Vision/physiology , Oxygen Consumption/physiology , Photic Stimulation
2.
Front Immunol ; 12: 643852, 2021.
Article in English | MEDLINE | ID: mdl-33692812

ABSTRACT

Since the late 1980s, mice have been repopulated with human hematopoietic cells to study the fundamental biology of human hematopoiesis and immunity, as well as a broad range of human diseases in vivo. Multiple mouse recipient strains have been developed and protocols optimized to efficiently generate these "humanized" mice. Here, we review three guiding principles that have been applied to the development of the currently available models: (1) establishing tolerance of the mouse host for the human graft; (2) opening hematopoietic niches so that they can be occupied by human cells; and (3) providing necessary support for human hematopoiesis. We then discuss four remaining challenges: (1) human hematopoietic lineages that poorly develop in mice; (2) limited antigen-specific adaptive immunity; (3) absent tolerance of the human immune system for its mouse host; and (4) sub-functional interactions between human immune effectors and target mouse tissues. While major advances are still needed, the current models can already be used to answer specific, clinically-relevant questions and hopefully inform the development of new, life-saving therapies.


Subject(s)
Adaptive Immunity , Disease Models, Animal , Hematopoiesis/immunology , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/immunology , Animals , Heterografts , Humans , Mice
3.
Trends Biotechnol ; 39(2): 107-110, 2021 02.
Article in English | MEDLINE | ID: mdl-32718779

ABSTRACT

Biotechnology has a Valley of Death challenge. Arrhenius's model is used to consider this journey by visualizing the factors critical to identifying appropriate business models. Examples illustrate this interplay and the routes to industrial readiness. The insights provided are useful to research and development managers, policy makers, entrepreneurs, and biotechnologists.


Subject(s)
Biotechnology , Industry , Models, Theoretical , Biotechnology/methods , Biotechnology/trends , Commerce
4.
Proc Natl Acad Sci U S A ; 116(9): 3530-3535, 2019 02 26.
Article in English | MEDLINE | ID: mdl-30808746

ABSTRACT

Glucose metabolism in vertebrate retinas is dominated by aerobic glycolysis (the "Warburg Effect"), which allows only a small fraction of glucose-derived pyruvate to enter mitochondria. Here, we report evidence that the small fraction of pyruvate in photoreceptors that does get oxidized by their mitochondria is required for visual function, photoreceptor structure and viability, normal neuron-glial interaction, and homeostasis of retinal metabolism. The mitochondrial pyruvate carrier (MPC) links glycolysis and mitochondrial metabolism. Retina-specific deletion of MPC1 results in progressive retinal degeneration and decline of visual function in both rod and cone photoreceptors. Using targeted-metabolomics and 13C tracers, we found that MPC1 is required for cytosolic reducing power maintenance, glutamine/glutamate metabolism, and flexibility in fuel utilization.


Subject(s)
Mitochondria/metabolism , Mitochondrial Membrane Transport Proteins/genetics , Retina/metabolism , Vision, Ocular/genetics , Animals , Glucose/metabolism , Glycolysis/genetics , Humans , Mice , Mitochondria/genetics , Mitochondrial Membrane Transport Proteins/metabolism , Monocarboxylic Acid Transporters , Pyruvic Acid/metabolism , Retina/pathology , Retinal Cone Photoreceptor Cells/metabolism , Retinal Cone Photoreceptor Cells/pathology , Retinal Degeneration , Retinal Rod Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/pathology
5.
Exp Eye Res ; 174: 113-120, 2018 09.
Article in English | MEDLINE | ID: mdl-29864440

ABSTRACT

Metabolomics studies in the retina and retinal pigment epithelium (RPE) in animal models or postmortem donors are essential to understanding the retinal metabolism and to revealing the underlying mechanisms of retinal degenerative diseases. We have studied how different methods of euthanasia (CO2 or cervical dislocation) different isolation procedures and postmortem delay affect metabolites in mouse retina and RPE/choroid using LC MS/MS and GC MS. Compared with cervical dislocation, CO2 exposure for 5 min dramatically degrades ATP and GTP into purine metabolites in the retina while raising intermediates in glucose metabolism and amino acids in the RPE/choroid. Isolation in cold buffer containing glucose has the least change in metabolites. Postmortem delay time-dependently and differentially impacts metabolites in the retina and RPE/choroid. In the postmortem retina, 18% of metabolites were changed at 0.5 h (h), 41% at 4 h and 51% at 8 h. However, only 6% of metabolites were changed in the postmortem RPE/choroid and it steadily increased to 20% at 8 h. Notably, both postmortem retina and RPE/choroid tissue showed increased purine metabolites. Storage of eyes in cold nutrient-rich medium substantially blocked the postmortem change in the retina and RPE/choroid. In conclusion, our study provides optimized methods to prepare fresh or postmortem retina and RPE/choroid tissue for metabolomics studies.


Subject(s)
Carbon Dioxide/pharmacology , Choroid , Dissection , Euthanasia , Metabolome/drug effects , Retinal Pigment Epithelium , Adenosine Triphosphate/metabolism , Animals , Choroid/drug effects , Choroid/metabolism , Chromatography, Liquid , Disease Models, Animal , Glucose/metabolism , Guanosine Triphosphate/metabolism , Mice , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/metabolism , Tandem Mass Spectrometry , Time Factors
6.
Adv Exp Med Biol ; 1074: 289-295, 2018.
Article in English | MEDLINE | ID: mdl-29721955

ABSTRACT

Aryl-hydrocarbon receptor interacting protein-like 1 (AIPL1) is essential to stabilize cGMP phosphodiesterase 6 (PDE6) in rod photoreceptors. Mutation of AIPL1 leads to loss of PDE6, accumulation of intracellular cGMP, and rapid degeneration of rods. To understand the metabolic basis for the photoreceptor degeneration caused by excessive cGMP, we performed proteomics and phosphoproteomics analyses on retinas from AIPL1-/- mice at the onset of rod cell death. AIPL1-/- retinas have about 18 times less than normal PDE6a and no detectable PDE6b. We identified twelve other proteins and thirty-nine phosphorylated proteins related to cell metabolism that are significantly altered preceding the massive degeneration of rods. They include transporters, kinases, phosphatases, transferases, and proteins involved in mitochondrial bioenergetics and metabolism of glucose, lipids, amino acids, nucleotides, and RNA. In AIPLI-/- retinas mTOR and proteins involved in mitochondrial energy production and lipid synthesis are more dephosphorylated, but glycolysis proteins and proteins involved in leucine catabolism are more phosphorylated than in normal retinas. Our findings indicate that elevating cGMP rewires cellular metabolism prior to photoreceptor degeneration and that targeting metabolism may be a productive strategy to prevent or slow retinal degeneration.


Subject(s)
Cyclic GMP/metabolism , Energy Metabolism/genetics , Eye Proteins/metabolism , Phosphoproteins/metabolism , Protein Processing, Post-Translational , Retina/metabolism , Retinal Degeneration/metabolism , Retinal Rod Photoreceptor Cells/pathology , Adaptor Proteins, Signal Transducing/deficiency , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/physiology , Animals , Cyclic Nucleotide Phosphodiesterases, Type 6/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Phosphorylation , Retina/pathology , Retinal Degeneration/pathology , Retinal Rod Photoreceptor Cells/metabolism
7.
Cell Death Dis ; 9(2): 240, 2018 02 14.
Article in English | MEDLINE | ID: mdl-29445082

ABSTRACT

Pyruvate kinase M2 (PKM2) is a glycolytic enzyme that is expressed in cancer cells. Its role in tumor metabolism is not definitively established, but investigators have suggested that regulation of PKM2 activity can cause accumulation of glycolytic intermediates and increase flux through the pentose phosphate pathway. Recent evidence suggests that PKM2 also may have non-metabolic functions, including as a transcriptional co-activator in gene regulation. We reported previously that PKM2 is abundant in photoreceptor cells in mouse retinas. In the present study, we conditionally deleted PKM2 (rod-cre PKM2-KO) in rod photoreceptors and found that the absence of PKM2 causes increased expression of PKM1 in rods. Analysis of metabolic flux from U-13C glucose shows that rod-cre PKM2-KO retinas accumulate glycolytic intermediates, consistent with an overall reduction in the amount of pyruvate kinase activity. Rod-cre PKM2-KO mice also have an increased NADPH availability could favor lipid synthesis, but we found no difference in phospholipid synthesis between rod-cre PKM2 KO and PKM2-positive controls. As rod-cre PKM2-KO mice aged, we observed a significant loss of rod function, reduced thickness of the photoreceptor outer segment layer, and reduced expression of photoreceptor proteins, including PDE6ß. The rod-cre PKM2-KO retinas showed greater TUNEL staining than wild-type retinas, indicating a slow retinal degeneration. In vitro analysis showed that PKM2 can regulate transcriptional activity from the PDE6ß promoter in vitro. Our findings indicate that both the metabolic and transcriptional regulatory functions of PKM2 may contribute to photoreceptor structure, function, and viability.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 6/genetics , Pyruvate Kinase/genetics , Retinal Cone Photoreceptor Cells/metabolism , Retinal Degeneration/genetics , Transcription, Genetic , Animals , Apoptosis/genetics , Carbon Isotopes , Cell Membrane/chemistry , Cell Membrane/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 6/metabolism , Disease Models, Animal , Electroretinography , Gene Expression Regulation , Humans , In Situ Nick-End Labeling , Integrases/genetics , Integrases/metabolism , Mice , Mice, Knockout , NADP/metabolism , Phospholipids/metabolism , Promoter Regions, Genetic , Protein Binding , Protein Isoforms/genetics , Protein Isoforms/metabolism , Pyruvate Kinase/deficiency , Retinal Cone Photoreceptor Cells/pathology , Retinal Degeneration/diagnostic imaging , Retinal Degeneration/metabolism , Retinal Degeneration/pathology , Signal Transduction , Staining and Labeling/methods , Tomography, Optical Coherence , Triglycerides/metabolism
8.
Trends Biotechnol ; 36(7): 642-645, 2018 07.
Article in English | MEDLINE | ID: mdl-29310840

ABSTRACT

The BRICS countries (Brazil, Russia, India, China, South Africa) account for 25% of global biotechnology patents. To understand the current and future landscape of the domain, it is important to better understand the capacity of these contributors. Here, we consider the thematic priorities, strategies, and key players of the BRICS countries in biotechnology patenting.


Subject(s)
Biotechnology , Patents as Topic , Biotechnology/legislation & jurisprudence , Biotechnology/statistics & numerical data , Brazil , China , Humans , India , Patents as Topic/legislation & jurisprudence , Patents as Topic/statistics & numerical data , Russia , South Africa
9.
Elife ; 62017 09 13.
Article in English | MEDLINE | ID: mdl-28901286

ABSTRACT

Here we report multiple lines of evidence for a comprehensive model of energy metabolism in the vertebrate eye. Metabolic flux, locations of key enzymes, and our finding that glucose enters mouse and zebrafish retinas mostly through photoreceptors support a conceptually new model for retinal metabolism. In this model, glucose from the choroidal blood passes through the retinal pigment epithelium to the retina where photoreceptors convert it to lactate. Photoreceptors then export the lactate as fuel for the retinal pigment epithelium and for neighboring Müller glial cells. We used human retinal epithelial cells to show that lactate can suppress consumption of glucose by the retinal pigment epithelium. Suppression of glucose consumption in the retinal pigment epithelium can increase the amount of glucose that reaches the retina. This framework for understanding metabolic relationships in the vertebrate retina provides new insights into the underlying causes of retinal disease and age-related vision loss.


Subject(s)
Adaptation, Ocular , Energy Metabolism , Ependymoglial Cells/physiology , Photoreceptor Cells/physiology , Retinal Pigment Epithelium/physiology , Animals , Ependymoglial Cells/metabolism , Glucose/metabolism , Humans , Lactates/metabolism , Mice , Photoreceptor Cells/metabolism , Retinal Pigment Epithelium/metabolism , Zebrafish
10.
Methods Enzymol ; 561: 149-70, 2015.
Article in English | MEDLINE | ID: mdl-26358904

ABSTRACT

Vertebrate retinas have several characteristics that make them particularly interesting from a metabolic perspective. The retinas have a highly laminated structure, high energy demands, and they share several metabolic features with tumors, such as a strong Warburg effect and abundant pyruvate kinase M2 isoform expression. The energy demands of retinas are both qualitatively and quantitatively different in light and darkness and metabolic dysfunction could cause retinal degeneration. Stable isotope-based metabolic analysis with mass spectrometry is a powerful tool to trace the dynamic metabolic reactions and reveal novel metabolic pathways within cells and between cells in retina. Here, we describe methods to quantify retinal metabolism in intact retinas and discuss applications of these methods to the understanding of neuron-glia interaction, light and dark adaptation, and retinal degenerative diseases.


Subject(s)
Energy Metabolism , Isotope Labeling/methods , Mass Spectrometry/methods , Retina/metabolism , Animals , Darkness , Light , Neuroglia/metabolism , Neurons/metabolism
11.
Proc Natl Acad Sci U S A ; 111(43): 15579-84, 2014 Oct 28.
Article in English | MEDLINE | ID: mdl-25313047

ABSTRACT

Symbiotic relationships between neurons and glia must adapt to structures, functions, and metabolic roles of the tissues they are in. We show here that Müller glia in retinas have specific enzyme deficiencies that can enhance their ability to synthesize Gln. The metabolic cost of these deficiencies is that they impair the Müller cell's ability to metabolize Glc. We show here that the cells can compensate for this deficiency by using metabolites produced by neurons. Müller glia are deficient for pyruvate kinase (PK) and for aspartate/glutamate carrier 1 (AGC1), a key component of the malate-aspartate shuttle. In contrast, photoreceptor neurons express AGC1 and the M2 isoform of pyruvate kinase, which is commonly associated with aerobic glycolysis in tumors, proliferating cells, and some other cell types. Our findings reveal a previously unidentified type of metabolic relationship between neurons and glia. Müller glia compensate for their unique metabolic adaptations by using lactate and aspartate from neurons as surrogates for their missing PK and AGC1.


Subject(s)
Amino Acid Transport Systems, Acidic/metabolism , Antiporters/metabolism , Neuroglia/metabolism , Pyruvate Kinase/metabolism , Retinal Neurons/metabolism , Animals , Aspartic Acid/metabolism , Carbon Isotopes , Cells, Cultured , Ependymoglial Cells/metabolism , Ependymoglial Cells/radiation effects , Glucose/metabolism , Glutamine/metabolism , Glycolysis , HeLa Cells , Humans , Isoenzymes/metabolism , Lactose/metabolism , Light , Mice , Models, Biological , Neuroglia/radiation effects , Oxidation-Reduction/radiation effects , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/radiation effects , Retinal Neurons/radiation effects
12.
N Biotechnol ; 31(2): 172-8, 2014 Mar 25.
Article in English | MEDLINE | ID: mdl-24361531

ABSTRACT

This paper presents work toward improving the efficacy of financial models that describe the unique nature of biotechnology firms. We show that using a 'thick tailed' power law distribution to describe the behavior of the value of biotechnology R&D used in a Real Options Pricing model is significantly more accurate than the traditionally used Gaussian approach. A study of 287 North-American biotechnology firms gives insights into common problems faced by investors, managers and other stakeholders when using traditional techniques to calculate the commercial value of R&D. This is important because specific quantitative tools to assess the value of high-risk, high-reward R&D do not currently exist. This often leads to an undervaluation of biotechnology R&D and R&D intensive biotechnology firms. For example, the widely used Net Present Value (NPV) method assumes a fixed risk ignoring management flexibility and the changing environment. However, Real Options Pricing models assume that commercial returns from R&D investments are described by a normal random walk. A normal random walk model eliminates the possibility of drastic changes to the marketplace resulting from the introduction of revolutionary products and/or services. It is possible to better understand and manage biotechnology research projects and portfolios using a model that more accurately considers large non-Gaussian price fluctuations with thick tails, which recognize the unusually large risks and opportunities associated with Biotechnology R&D. Our empirical data show that opportunity overcompensates for the downside risk making biotechnology R&D statistically more valuable than other Gaussian options investments, which may otherwise appear to offer a similar combination of risk and return.


Subject(s)
Biomedical Research , Biotechnology , Models, Economic , Biomedical Research/economics , Biomedical Research/trends , Biotechnology/economics , Biotechnology/trends , North America
14.
Proc Natl Acad Sci U S A ; 110(46): 18501-6, 2013 Nov 12.
Article in English | MEDLINE | ID: mdl-24127593

ABSTRACT

Glutamate in neurons is an important excitatory neurotransmitter, but it also is a key metabolite. We investigated how glutamate in a neural tissue is protected from catabolism. Flux analysis using (13)C-labeled fuels revealed that retinas use activities of the malate aspartate shuttle to protect >98% of their glutamate from oxidation in mitochondria. Isolation of glutamate from the oxidative pathway relies on cytosolic NADH/NAD(+), which is influenced by extracellular glucose, lactate, and pyruvate.


Subject(s)
Cytosol/metabolism , Glutamic Acid/metabolism , Retina/metabolism , Analysis of Variance , Animals , Carbon Isotopes/metabolism , Gas Chromatography-Mass Spectrometry , HeLa Cells , Humans , Metabolic Flux Analysis , Mice , Mice, Inbred C57BL , Models, Biological , Oxidation-Reduction
15.
Proc Natl Acad Sci U S A ; 109(6): E368-77, 2012 Feb 07.
Article in English | MEDLINE | ID: mdl-22223655

ABSTRACT

Na(V)1.1 is the primary voltage-gated Na(+) channel in several classes of GABAergic interneurons, and its reduced activity leads to reduced excitability and decreased GABAergic tone. Here, we show that Na(V)1.1 channels are expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus. Mice carrying a heterozygous loss of function mutation in the Scn1a gene (Scn1a(+/-)), which encodes the pore-forming α-subunit of the Na(V)1.1 channel, have longer circadian period than WT mice and lack light-induced phase shifts. In contrast, Scn1a(+/-) mice have exaggerated light-induced negative-masking behavior and normal electroretinogram, suggesting an intact retina light response. Scn1a(+/-) mice show normal light induction of c-Fos and mPer1 mRNA in ventral SCN but impaired gene expression responses in dorsal SCN. Electrical stimulation of the optic chiasm elicits reduced calcium transients and impaired ventro-dorsal communication in SCN neurons from Scn1a(+/-) mice, and this communication is barely detectable in the homozygous gene KO (Scn1a(-/-)). Enhancement of GABAergic transmission with tiagabine plus clonazepam partially rescues the effects of deletion of Na(V)1.1 on circadian period and phase shifting. Our report demonstrates that a specific voltage-gated Na(+) channel and its associated impairment of SCN interneuronal communication lead to major deficits in the function of the master circadian pacemaker. Heterozygous loss of Na(V)1.1 channels is the underlying cause for severe myoclonic epilepsy of infancy; the circadian deficits that we report may contribute to sleep disorders in severe myoclonic epilepsy of infancy patients.


Subject(s)
Cell Communication , Circadian Rhythm/physiology , Extracellular Space/metabolism , Nerve Tissue Proteins/metabolism , Sodium Channels/metabolism , Suprachiasmatic Nucleus/cytology , Suprachiasmatic Nucleus/metabolism , Animals , Behavior, Animal/radiation effects , CLOCK Proteins/genetics , CLOCK Proteins/metabolism , Cell Communication/genetics , Cell Communication/radiation effects , Circadian Rhythm/genetics , Circadian Rhythm/radiation effects , Electroretinography , Extracellular Space/radiation effects , Female , GABAergic Neurons/cytology , GABAergic Neurons/metabolism , Gene Expression Regulation/radiation effects , Light , Male , Mice , Mice, Inbred C57BL , NAV1.1 Voltage-Gated Sodium Channel , Phenotype , Photic Stimulation , Signal Transduction/genetics , Suprachiasmatic Nucleus/radiation effects , Synaptic Transmission/genetics , Synaptic Transmission/radiation effects
16.
J Biol Chem ; 286(40): 34700-11, 2011 Oct 07.
Article in English | MEDLINE | ID: mdl-21840997

ABSTRACT

Vertebrate photoreceptor neurons have a high demand for metabolic energy, and their viability is very sensitive to genetic and environmental perturbations. We investigated the relationship between energy metabolism and cell death by evaluating the metabolic effects of glucose deprivation on mouse photoreceptors. Oxygen consumption, lactate production, ATP, NADH/NAD(+), TCA cycle intermediates, morphological changes, autophagy, and viability were evaluated. We compared retinas incubated with glucose to retinas deprived of glucose or retinas treated with a mixture of mitochondrion-specific fuels. Rapid and slow phases of cell death were identified. The rapid phase is linked to reduced mitochondrial activity, and the slower phase reflects a need for substrates for cell maintenance and repair.


Subject(s)
Glucose/metabolism , Neurons/metabolism , Photoreceptor Cells, Vertebrate/metabolism , Acetylglucosamine/metabolism , Adenosine Triphosphate/metabolism , Animals , Autophagy , Cell Death , Cell Survival , Gas Chromatography-Mass Spectrometry/methods , Lactic Acid/metabolism , Mice , Mice, Inbred C57BL , Mitochondria/metabolism , NAD/metabolism , Neurodegenerative Diseases/metabolism , Oxygen Consumption , Retina/metabolism
17.
Proc Natl Acad Sci U S A ; 107(19): 8599-604, 2010 May 11.
Article in English | MEDLINE | ID: mdl-20445106

ABSTRACT

Structural features of neurons create challenges for effective production and distribution of essential metabolic energy. We investigated how metabolic energy is distributed between cellular compartments in photoreceptors. In avascular retinas, aerobic production of energy occurs only in mitochondria that are located centrally within the photoreceptor. Our findings indicate that metabolic energy flows from these central mitochondria as phosphocreatine toward the photoreceptor's synaptic terminal in darkness. In light, it flows in the opposite direction as ATP toward the outer segment. Consistent with this model, inhibition of creatine kinase in avascular retinas blocks synaptic transmission without influencing outer segment activity. Our findings also reveal how vascularization of neuronal tissue can influence the strategies neurons use for energy management. In vascularized retinas, mitochondria in the synaptic terminals of photoreceptors make neurotransmission less dependent on creatine kinase. Thus, vasculature of the tissue and the intracellular distribution of mitochondria can play key roles in setting the strategy for energy distribution in neurons.


Subject(s)
Darkness , Energy Metabolism/physiology , Retina/physiology , Animals , Creatine Kinase/antagonists & inhibitors , Creatine Kinase/metabolism , Dinitrofluorobenzene/pharmacology , Electroretinography , Energy Metabolism/drug effects , Energy Metabolism/radiation effects , Glutamates/metabolism , Mice , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/radiation effects , Models, Biological , Presynaptic Terminals/drug effects , Presynaptic Terminals/enzymology , Presynaptic Terminals/radiation effects , Protein Kinase Inhibitors/pharmacology , Retina/drug effects , Retina/enzymology , Retina/radiation effects , Retinal Cone Photoreceptor Cells/cytology , Retinal Cone Photoreceptor Cells/drug effects , Retinal Cone Photoreceptor Cells/enzymology , Retinal Cone Photoreceptor Cells/radiation effects , Retinal Photoreceptor Cell Outer Segment/drug effects , Retinal Photoreceptor Cell Outer Segment/metabolism , Retinal Photoreceptor Cell Outer Segment/radiation effects , Retinal Vessels/drug effects , Retinal Vessels/enzymology , Retinal Vessels/radiation effects , Synaptic Transmission/drug effects , Synaptic Transmission/radiation effects , Urodela/physiology
18.
J Environ Manage ; 77(1): 22-34, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15949891

ABSTRACT

Evolutionary simulation-optimization (ESO) techniques can be adapted to model a wide variety of problem types in which system components are stochastic. Grey programming (GP) methods have been previously applied to numerous environmental planning problems containing uncertain information. In this paper, ESO is combined with GP for policy planning to create a hybrid solution approach named GESO. It can be shown that multiple policy alternatives meeting required system criteria, or modelling-to-generate-alternatives (MGA), can be quickly and efficiently created by applying GESO to this case data. The efficacy of GESO is illustrated using a municipal solid waste management case taken from the regional municipality of Hamilton-Wentworth in the Province of Ontario, Canada. The MGA capability of GESO is especially meaningful for large-scale real-world planning problems and the practicality of this procedure can easily be extended from MSW systems to many other planning applications containing significant sources of uncertainty.


Subject(s)
Computer Simulation , Environment , Models, Theoretical , Refuse Disposal , Waste Management/methods , Decision Making , Forecasting , Humans , Planning Techniques , Refuse Disposal/methods
19.
Nat Mater ; 2(5): 287-9, 2003 May.
Article in English | MEDLINE | ID: mdl-12728227
SELECTION OF CITATIONS
SEARCH DETAIL
...